- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- February 2026
- 250 Pages
Global
From €4005EUR$4,490USD£3,435GBP
- Report
- June 2026
- 150 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- January 2026
- 183 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- January 2026
- 194 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- January 2026
- 191 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- January 2026
- 198 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- December 2025
- 82 Pages
Global
From €4371EUR$4,900USD£3,749GBP
- Report
- October 2025
Global
From €4371EUR$4,900USD£3,749GBP
- Report
- September 2026
- 199 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- September 2026
- 181 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- September 2026
- 193 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- September 2026
- 192 Pages
Global
From €3162EUR$3,545USD£2,712GBP
€3513EUR$3,939USD£3,013GBP
- Report
- September 2026
- 390 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 182 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 276 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 288 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 351 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 208 Pages
Global
From €5218EUR$5,850USD£4,475GBP
- Report
- September 2026
- 349 Pages
Global
From €5218EUR$5,850USD£4,475GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more